JP2017525489A - 炎症性メディエーター並びに顆粒球及び単球を血液から除去するためのシステム - Google Patents
炎症性メディエーター並びに顆粒球及び単球を血液から除去するためのシステム Download PDFInfo
- Publication number
- JP2017525489A JP2017525489A JP2017510850A JP2017510850A JP2017525489A JP 2017525489 A JP2017525489 A JP 2017525489A JP 2017510850 A JP2017510850 A JP 2017510850A JP 2017510850 A JP2017510850 A JP 2017510850A JP 2017525489 A JP2017525489 A JP 2017525489A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- membrane
- housing
- monocytes
- outlet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 131
- 239000008280 blood Substances 0.000 title claims abstract description 131
- 210000003714 granulocyte Anatomy 0.000 title claims abstract description 36
- 210000001616 monocyte Anatomy 0.000 title claims abstract description 36
- 230000002757 inflammatory effect Effects 0.000 title claims description 24
- 239000012528 membrane Substances 0.000 claims abstract description 120
- 238000001914 filtration Methods 0.000 claims abstract description 39
- 239000012466 permeate Substances 0.000 claims abstract description 32
- 239000012465 retentate Substances 0.000 claims abstract description 30
- 230000017531 blood circulation Effects 0.000 claims abstract description 20
- 239000012530 fluid Substances 0.000 claims abstract description 19
- 238000007873 sieving Methods 0.000 claims abstract description 17
- 238000004891 communication Methods 0.000 claims abstract description 16
- 108010088751 Albumins Proteins 0.000 claims abstract description 14
- 102000009027 Albumins Human genes 0.000 claims abstract description 14
- 238000000926 separation method Methods 0.000 claims abstract description 14
- 238000012545 processing Methods 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000012510 hollow fiber Substances 0.000 claims description 25
- 238000001179 sorption measurement Methods 0.000 claims description 24
- 229940027941 immunoglobulin g Drugs 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 239000003463 adsorbent Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 4
- 230000007717 exclusion Effects 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 230000024203 complement activation Effects 0.000 claims description 2
- 150000001875 compounds Chemical group 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 229920000620 organic polymer Polymers 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 17
- 102000004127 Cytokines Human genes 0.000 description 16
- 108090000695 Cytokines Proteins 0.000 description 16
- 229920000642 polymer Polymers 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 206010040047 Sepsis Diseases 0.000 description 9
- 210000000265 leukocyte Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000008718 systemic inflammatory response Effects 0.000 description 3
- 239000004695 Polyether sulfone Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- -1 antibodies Proteins 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920006393 polyether sulfone Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000110 poly(aryl ether sulfone) Polymers 0.000 description 1
- 229920001643 poly(ether ketone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920012287 polyphenylene sulfone Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A61M1/3406—Physical characteristics of the filtrate, e.g. urea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A61M1/341—Regulation parameters by measuring the filtrate rate or volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/02—Hollow fibre modules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0014—Special media to be introduced, removed or treated removed from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
- A61M2202/0441—Granulocytes, i.e. leucocytes containing many granules in their cytoplasm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
- A61M2202/0443—Macrophages, e.g. monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0445—Proteins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/20—Specific permeability or cut-off range
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D39/00—Filtering material for liquid or gaseous fluids
- B01D39/14—Other self-supporting filtering material ; Other filtering material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14182261.9 | 2014-08-26 | ||
| EP14182261 | 2014-08-26 | ||
| PCT/EP2015/069415 WO2016030357A1 (de) | 2014-08-26 | 2015-08-25 | System zur entfernung von proinflammatorischen mediatoren sowie von granulozyten und monozyten aus blut |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017525489A true JP2017525489A (ja) | 2017-09-07 |
| JP2017525489A5 JP2017525489A5 (enExample) | 2018-10-04 |
Family
ID=51392162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510850A Withdrawn JP2017525489A (ja) | 2014-08-26 | 2015-08-25 | 炎症性メディエーター並びに顆粒球及び単球を血液から除去するためのシステム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20170266362A1 (enExample) |
| EP (1) | EP3185926B1 (enExample) |
| JP (1) | JP2017525489A (enExample) |
| CN (1) | CN106659834B (enExample) |
| WO (1) | WO2016030357A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3473327A1 (en) | 2017-10-19 | 2019-04-24 | 3M Innovative Properties Company | Integrated fluid treatment device, and process using such device |
| US20220273855A1 (en) * | 2019-08-01 | 2022-09-01 | Seastar Medical, Inc. | Device and method for preparing a donor organ for transplantation |
| CN112511569B (zh) * | 2021-02-07 | 2021-05-11 | 杭州筋斗腾云科技有限公司 | 网络资源访问请求的处理方法、系统及计算机设备 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2077137B (en) | 1980-03-12 | 1983-09-07 | Asahi Chemical Ind | Granulocyte-separating material and granulocyte separator |
| DE3578502D1 (de) | 1984-03-15 | 1990-08-09 | Asahi Medical Co | Filtereinheit zum abtrennen von leukozyten. |
| JP2673567B2 (ja) | 1987-12-10 | 1997-11-05 | 株式会社日本抗体研究所 | 血液中の顆粒球除去方法及びこれに用いる顆粒球除去装置 |
| DE69119683T2 (de) | 1990-07-27 | 1996-10-02 | Pall Corp | Filtereinrichtung zur Entfernung von Leukozyten und Methode zur Verwendung |
| ATE197547T1 (de) | 1991-08-22 | 2000-12-15 | Asahi Medical Co | Filtermedium zur selektiven entfernung von leukozyten und entsprechende vorrichtung |
| DE69314154T2 (de) | 1992-12-28 | 1998-04-30 | Asahi Medical Co | Filtermaterial, Vorrichtung und Verfahren zum Abtrennen von Leukozyten |
| US5571418A (en) | 1993-08-20 | 1996-11-05 | Lee; Patrice A. | Hemofiltration of toxic mediator-related disease |
| ES2234183T3 (es) | 1996-02-06 | 2005-06-16 | Bellco S.P.A. | Separacion por absorcion de citoquinas de un paciente afectado por el fallo agudo de un organo. |
| KR100343092B1 (ko) | 1997-08-28 | 2002-07-05 | 추후보충 | 백혈구-제거용 여과재 |
| US6287516B1 (en) | 1998-07-10 | 2001-09-11 | Immunocept, L.L.C. | Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease |
| JP4643830B2 (ja) | 1999-03-17 | 2011-03-02 | 株式会社Jimro | 疾患の処置 |
| DE19913707A1 (de) | 1999-03-26 | 2000-10-05 | Privates Inst Bioserv Gmbh | Immunadsorber zur Sepsistherapie |
| EP1409041A4 (en) | 2001-07-25 | 2007-05-16 | Immunocept L L C | HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS |
| WO2003033053A1 (en) | 2001-10-16 | 2003-04-24 | Asahi Medical Co., Ltd. | Method of selectively eliminating virus and leukocytes, eliminating material and eliminating apparatus |
| ATE414724T1 (de) | 2002-06-17 | 2008-12-15 | Asahi Kasei Kuraray Medical Co | Biokompatibles polymer und filter zur selektiven eliminierung von leukozyten mit dem polymer |
| ITTO20020736A1 (it) | 2002-08-21 | 2004-02-22 | Fresenius Hemocare Italia Srl | Filtro per leucociti e suo impiego per l'impoverimento di prodotti del sangue da leucociti. |
| JP2006503670A (ja) | 2002-10-25 | 2006-02-02 | ポール コーポレイション | 生物学的流体フィルタ |
| EP1582228B2 (en) | 2002-12-02 | 2019-03-13 | Asahi Kasei Medical Co., Ltd. | Method of removing leukocytes, leukocyte-removing filter and utilization thereof |
| SE0203855L (sv) * | 2002-12-20 | 2004-06-21 | Gambro Lundia Ab | Permselektivt membran |
| ITTO20030039A1 (it) | 2003-01-24 | 2004-07-25 | Fresenius Hemocare Italia Srl | Filtro per separare leucociti da sangue intero e/o da preparati derivati dal sangue, procedimento per la fabbricazione del filtro, dispositivo e utilizzazione. |
| DE60311240T2 (de) | 2003-07-03 | 2007-07-05 | Fresenius Hemocare Italia S.R.L., Cavezzo | Filter zur Entfernung von Substanzen aus Blutprodukten |
| US8999167B2 (en) | 2003-08-07 | 2015-04-07 | Asahi Kasei Medical Co., Ltd. | Composite porous membrane and process for producing the same |
| ES2562354T3 (es) | 2004-06-09 | 2016-03-03 | Asahi Kasei Medical Co., Ltd. | Procedimiento para eliminar leucocitos y filtro para su utilización en el mismo |
| CN101057141B (zh) * | 2004-07-30 | 2012-11-07 | 普拉里斯莱克特有限公司 | 一种从流体中分离细胞、生物颗粒和/或分子以应用于动物、生物技术（包括生物学研究）和医疗诊断的方法和仪器 |
| JP4787842B2 (ja) | 2004-12-10 | 2011-10-05 | フレゼニウス・ヘモケア・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ | とくに生体液を濾過するための多孔性ウェブ |
| US20090311770A1 (en) | 2005-05-20 | 2009-12-17 | Arkray, Inc. | Method of collecting microorganisms using fine particles, method of collecting nucleic acids using fine particles, and kits for use in the these methods |
| EP1931445B1 (en) | 2005-08-31 | 2018-08-01 | Gambro Lundia AB | Cyclic olefin copolymer as a leukoreduction material |
| KR101256363B1 (ko) | 2005-09-09 | 2013-04-25 | 멤브라나 게엠베하 | 혈액으로부터 백혈구의 제거방법 |
| EP1897571A1 (en) | 2006-09-06 | 2008-03-12 | Fresenius Hemocare Italia S.r.l. | A filter for the removal of substances from blood products |
| EP1944046B1 (en) | 2007-01-12 | 2010-08-11 | Bellco S.r.l. | Kit for treating a systematic inflammation related diseases |
| WO2008083965A2 (de) * | 2007-01-13 | 2008-07-17 | Membrana Gmbh | Vorrichtung zur entfernung von leukozyten aus blut |
| ES3033913T3 (en) * | 2007-08-31 | 2025-08-11 | Seastar Medical Inc | Selective cytopheresis devices |
| TWI446939B (zh) | 2008-04-14 | 2014-08-01 | Asahi Kasei Medical Co Ltd | The filter method for removing the filter material and the blood preparation |
| EP2380610B1 (en) * | 2010-04-20 | 2014-05-07 | Gambro Lundia AB | High cut-off hemodialysis membrane for use in liver dialysis |
| US10064406B2 (en) | 2011-01-06 | 2018-09-04 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
| CA2844688C (en) | 2011-08-12 | 2021-10-19 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
| EP2606921A1 (fr) * | 2011-12-21 | 2013-06-26 | Infomed SA | Dispositif d'épuration du sang par circulation extracorporelle |
| EP2735359B1 (en) * | 2012-11-26 | 2017-02-08 | Gambro Lundia AB | Integrated device for liver support systems |
-
2015
- 2015-08-25 JP JP2017510850A patent/JP2017525489A/ja not_active Withdrawn
- 2015-08-25 US US15/505,724 patent/US20170266362A1/en not_active Abandoned
- 2015-08-25 EP EP15763840.4A patent/EP3185926B1/de not_active Not-in-force
- 2015-08-25 WO PCT/EP2015/069415 patent/WO2016030357A1/de not_active Ceased
- 2015-08-25 CN CN201580045367.8A patent/CN106659834B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP3185926A1 (de) | 2017-07-05 |
| US20170266362A1 (en) | 2017-09-21 |
| CN106659834A (zh) | 2017-05-10 |
| CN106659834B (zh) | 2019-06-18 |
| WO2016030357A1 (de) | 2016-03-03 |
| EP3185926B1 (de) | 2018-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11433173B2 (en) | System for extracorporeal blood treatment, treatment apparatus, kit and method for operating a system for extracorporeal blood treatment | |
| US5858238A (en) | Salvage of autologous blood via selective membrane/sorption technologies | |
| CA2644732C (en) | Regeneratable filter for extracorporal treatment of liquids containing particles and use thereof | |
| AU2008303785B2 (en) | Hydrophilic membranes with a non-ionic surfactant | |
| EP2957306A1 (en) | Blood purification column | |
| US20240066470A1 (en) | Filtration media | |
| JP5843345B2 (ja) | β−アミロイド除去システム | |
| Geremia et al. | Ex vivo evaluation of the blood compatibility of mixed matrix haemodialysis membranes | |
| WO2013147001A1 (ja) | 血液製剤浄化用のポリスルホン系中空糸膜及び中空糸膜モジュール | |
| JP2002526172A (ja) | 生物学的流体フィルターおよびシステム | |
| KR101256363B1 (ko) | 혈액으로부터 백혈구의 제거방법 | |
| JP2017525489A (ja) | 炎症性メディエーター並びに顆粒球及び単球を血液から除去するためのシステム | |
| WO2021022115A1 (en) | Device and method for preparing a donor organ for transplantation | |
| JP5227271B2 (ja) | 血液からウイルス及びサイトカインを除去するシステム | |
| JP6312292B2 (ja) | 血液中β−アミロイド除去システム | |
| JP2005137996A (ja) | 選択透過性分離膜 | |
| JP2010136803A (ja) | 血液からウイルス及びサイトカインを除去するシステム | |
| Pavlenko | Towards improved removal of uremic toxins from human plasma | |
| JP2019193709A (ja) | アミロイド−β除去システム | |
| JP2006305306A (ja) | 血液浄化法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20180418 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20180420 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180824 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180824 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20190617 |